Skip to main content
  • Log in
  • Register
Canadian Urban Data Catalogue (CUDC)
    • Home
    • Add to Catalogue
      • Add to Catalogue
      • View Catalogue
    • Organizations
      • View Organizations
      • Create an Organization
      • View Organizations
      • Request to Join an Organization
    • About
    • FAQ
  1. CUDC
  2. Organizations
  3. Health Canada
  4. Summary Safety Review -...

Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the Risk of the Body Producing High Levels of Acids in the Blood (diabetic ketoacidosis)

Followers
0
hc-sc

Health Canada

There is no description for this organization

Social

  • Twitter
  • Facebook

License

Open Government Licence - Canada

  • Catalogue Entry
  • Groups
  • Activity Stream
  • Gravatar admin created the Catalogue Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the Risk of the Body Producing High Levels of Acids in the Blood (diabetic ketoacidosis)
    1 year ago
  • About Canadian Urban Data Catalogue (CUDC)
  • About Urban Data Centre
  • Maturity Model FAQ
  • CKAN API
  • CKAN Association
  • Open Data

Powered by CKAN